Martha: Guilty on All Counts
A jury has convicted Martha Stewart of lying to federal investigators about her sale of 3,298 shares of ImClone (IMCL ) stock on Dec. 27, 2001, the day before the Food & Drug Administration rejected the drug outfit's application for Erbitux, a cancer drug. The four charges carry a possible sentence of up to 20 years in prison.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.